DOI:
10.1055/s-00034925
Hämostaseologie
LinksClose Window
References
Møss J, Clausen WHO, Ezban M.
Measuring factor VIII activity in samples from patients treated with N8-GP (Esperoct®; turoctocog alfa pegol) during the pathfinder clinical trials programme.
Haemophilia 2021;
27 (03) e389-e392
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.